Drug production value Japan 2022, by category
In 2022, the production value of antineoplastic amounted to around 1434 billion Japanese yen. The other agents affecting metabolism followed with around 301 billion Japanese yen. The other agents affecting metabolism include agents such as for liver disease and antidotes, for habitual intoxication, for treatment of gout.